Embodiments herein relate to systems and devices for analyte sensing in physiological gas samples. More specifically, embodiments herein relate to systems and devices for measuring analyte presence on graphene varactors.
In the process of providing health care, clinicians often make physical observations and run tests to gather data about a patient. After collecting data and analyzing other aspects, such as a given patient's health history, the clinician often forms a diagnosis and then selects a therapy to treat the diagnosed condition.
Knowledge of the presence and/or concentrations of various chemical analytes, such as volatile organic compounds, can be extremely useful in forming a diagnosis. However, measuring such chemical analytes in a clinically practical manner remains technically challenging.
Embodiments herein relate to systems and devices for analyte sensing in physiological gas samples.
In a first aspect, a system for measuring analyte presence on a graphene varactor is included. The system can include a capacitance to digital converter (CDC) and a graphene varactor. The CDC can be in electrical communication with the graphene varactor and can be configured to measure the capacitance of the graphene varactor in response to an excitation signal over a plurality of DC bias voltages.
In a second aspect, in addition to or in place of other aspects herein, the system can further include a multiplexor configured to selectively provide electrical communication between the CDC and a plurality of graphene varactors.
In a third aspect, in addition to or in place of other aspects herein, an excitation signal can be applied to a selected graphene varactor through the multiplexor.
In a fourth aspect, in addition to or in place of other aspects herein, the excitation signal can include an alternating voltage component.
In a fifth aspect, in addition to or in place of other aspects herein, the amplitude of the excitation signal is fixed by the CDC.
In a sixth aspect, in addition to or in place of other aspects herein, a controller circuit can be included and can be configured to receive an electrical signal reflecting the capacitance of the graphene varactor.
In a seventh aspect, in addition to or in place of other aspects herein, the controller circuit can include a microcontroller.
In an eighth aspect, in addition to or in place of other aspects herein, the system further includes an electronic component in electrical communication with the controller circuit and the CDC, the electronic component selected from the group consisting of an I2C or an SPI.
In a ninth aspect, in addition to or in place of other aspects herein, the graphene varactor can include a functionalized graphene varactor.
In a tenth aspect, in addition to or in place of other aspects herein, the controller circuit is configured to calculate at least one parameter for the graphene varactor selected from the group consisting of maximum slope of capacitance to voltage; change in maximum slope of capacitance to voltage over a baseline value; minimum slope of capacitance to voltage; change in minimum slope of capacitance to voltage over a baseline value; minimum capacitance; change in minimum capacitance over a baseline value; voltage at minimum capacitance; change in voltage at minimum capacitance; maximum capacitance; change in maximum capacitance; ratio of maximum capacitance to minimum capacitance; response time constant; and ratios of any of the foregoing between the graphene varactor and a second graphene varactor.
In an eleventh aspect, in addition to or in place of other aspects herein, the graphene varactor(s) are grounded.
In a twelfth aspect, in addition to or in place of other aspects herein, the graphene varactor(s) are in electrical communication with an independent excitation output of the CDC.
In a thirteenth aspect, in addition to or in place of other aspects herein, the system can further include one or more programmable digital to analog converters (DACs) in series with the plurality of graphene sensors.
In a fourteenth aspect, in addition to or in place of other aspects herein, the system can further include a switch, the CDC in electrical communication with the switch and controlling the switch to selectively provide communication with output voltages of two programmable digital to analog converters (DACs), the programmed voltage difference between the DACs determining the excitation amplitude, and the difference between the programmed average voltage of the DACs and the bias at the CDC input determining the DC bias.
In a fifteenth aspect, a method for measuring analyte presence on a graphene varactor is included. The method can include measuring a capacitance of the graphene varactor over a range of DC bias voltages; comparing the measured capacitance at one or more DC bias voltages to one or more corresponding baseline capacitance values; and determining the presence or absence of an analyte based on the comparison.
In a sixteenth aspect, in addition to or in place of other aspects herein, the method can further include determining one or more aspects selected from the group consisting of maximum slope of capacitance to voltage; change in maximum slope of capacitance to voltage over a baseline value; minimum slope of capacitance to voltage; change in minimum slope of capacitance to voltage over a baseline value; minimum capacitance; change in minimum capacitance over a baseline value; voltage at minimum capacitance; change in voltage at minimum capacitance; maximum capacitance; change in maximum capacitance; ratio of maximum capacitance to minimum capacitance; response time constant; and ratios of any of the foregoing between two different graphene sensors.
In a seventeenth aspect, in addition to or in place of other aspects herein, the method can further include forming a capacitance to voltage curve from the measured capacitance of the graphene varactor over the range of DC bias voltages.
In an eighteenth aspect, in addition to or in place of other aspects herein, the method can further include comparing the formed capacitance to voltage curve with a baseline capacitance to voltage curve.
In a nineteenth aspect, in addition to or in place of other aspects herein, the method can further include distinguishing between different analytes binding to the graphene varactor.
In a twentieth aspect, in addition to or in place of other aspects herein, the range of DC bias voltages is from −3 V to 3 V.
This summary is an overview of some of the teachings of the present application and is not intended to be an exclusive or exhaustive treatment of the present subject matter. Further details are found in the detailed description and appended claims. Other aspects will be apparent to persons skilled in the art upon reading and understanding the following detailed description and viewing the drawings that form a part thereof, each of which is not to be taken in a limiting sense. The scope herein is defined by the appended claims and their legal equivalents.
Aspects may be more completely understood in connection with the following drawings, in which:
While embodiments are susceptible to various modifications and alternative forms, specifics thereof have been shown by way of example and drawings, and will be described in detail. It should be understood, however, that the scope herein is not limited to the particular embodiments described. On the contrary, the intention is to cover modifications, equivalents, and alternatives falling within the spirit and scope herein.
Volatile organic compounds, as sensed in breath samples or other gas samples, can provide valuable information about the health status of a patient. In particular, patterns of volatile organic compounds (including the presence, absence, and/or concentration of a plurality of different volatile organic compounds) in a breath or gas sample of a patient can be associated with various disease states and/or particular health statuses. The disease states can include, but are not limited to, lung cancer, colon cancer, pulmonary disease (e.g. asthma, COPD), cardiovascular disease (e.g. heart failure), infectious diseases, digestive and inflammatory diseases (e.g. inflammatory bowel diseases such as Crohn's, colitis, or the like) or diabetes.
Graphene varactors are one type of device that can be used to measure volatile organic compounds. Various properties of graphene varactors, such as capacitance, can change in response to the presence of volatile organic compounds thereon. However, measurement of properties of the graphene varactors, such as capacitance, remains technically challenging.
However, embodiments herein can be used to rapidly and accurately measure the capacitance of a plurality of graphene varactors.
Referring now to
The breath sensing device 160 can include a housing 178. The breath sensing device 160 can include a mouthpiece 162 into which a subject to be evaluated can blow a breath sample. The breath sensing device 160 can also include a display screen 174 and a user input device 176, such as a keyboard. The breath sensing device 160 can also include a gas outflow port 172. Aspects of breath sensing systems and devices are described in U.S. Publ. Appl. No. 2016/0109440, the content of which is herein incorporated by reference. While
In some embodiments, the system 100 can include a local computing device 182 that can include a microprocessor, input and output circuits, input devices, a visual display, a user interface, and the like. In some embodiments, the breath sensing device 160 can communicate with the local computing device 182 in order to exchange data between the breath sensing device 160 and the local computing device 182. The local computing device 182 can be configured to perform various processing steps with the data received from the breath sensing device 160, including, but not limited to, calculating various parameters described herein. However, it should be appreciated that in some embodiments the features associated with the local computing device 182 can be integrated into the breath sensing device 160. In some embodiments, the local computing device 182 can be a laptop computer, a desktop computer, a server (real or virtual), a purpose dedicated computer device, or a portable computing device (including, but not limited to, a mobile phone, tablet, wearable device, etc.).
The local computing device 182 and/or the breath sensing device 160 can communicate with computing devices in remote locations through a data network 184, such as the Internet or another network for the exchange of data as packets, frames, or otherwise.
In some embodiments, the system 100 can also include a computing device such as a server 186 (real or virtual). In some embodiments, the server 186 can be located remotely from the breath sensing device 160. The server 186 can be in data communication with a database 188.
The database 188 can be used to store various patient information, such as that described herein. In some embodiments, the database can specifically include an electronic medical database containing data regarding the health status of a patient, patterns of data associated with various conditions (such as that generated from machine learning analysis of large sets of patient data), demographic data and the like.
Graphene varactors can be prepared in various ways and with various geometries. Referring now to
In various embodiments, the graphene layer can be functionalized to make the graphene sensor specific for a particular analyte or class of analytes. As analytes bind to the graphene layer, the capacitance of the sensor changes. Further, as shown below with regard to
Systems herein can also include a breath and/or gas sensing device or system. In particular, systems herein can gather data on the presence, absence, and/or amount of various gaseous analytes including, but not limited to, volatile organic compounds.
The gas sampling device 410 can be configured to collect a gas sample and facilitate testing of the gas sample to generate data. In some embodiments, the gas sampling device 410 can be configured as a handheld device. In such cases, the gas sampling device can be configured to be held in the hand of a care provider, a patient, or both, during certain steps of its use, while also being configured to be held or otherwise positioned in association with the docking station 430 during certain steps of its use.
In some embodiments, the gas sampling device 410 is configured to receive a gas sample, such as exhaled breath, from a patient and direct the gas sample to a testing location. The gas sampling device 410 generally has a housing 420 defining an airflow aperture 422, a gas testing chamber 426, a sensor receptacle 428, an airflow pathway 424, and a docking structure 421.
When receiving a gas sample, the gas (such as breath from a patient), can pass into the gas sampling device 410 through the airflow aperture 422, through the airflow pathway 424, into the gas testing chamber 426 and into contact with one or more measurement zones 442 of a disposable sensor test strip 440, and then out the end of the gas testing chamber 426 through the sensor receptacle 428, or through a separate exhaust port (not shown in this view). While this view depicts contact in some areas between the sensor receptacle 428 and the disposable sensor test strip 440, it will be appreciated that there can be segments or areas where the sensor receptacle 428 and the disposable sensor test strip 440 do not contact or do not create sealing contact, thus allowing for a path for the gas to flow out through the sensor receptacle 428.
While
The housing 420 can be constructed of a variety of materials and combinations of materials. The housing 420 can be a single cohesive structure or can be constructed of multiple components that are coupled to form the housing 420. As an illustrative example, a portion of the housing 420 that defines the airflow pathway 424 can be coupled to the portion of the housing 420 that defines the airflow aperture 422. The portion of the housing 420 that defines the airflow pathway 424 can include a conduit or tube with various different cross-sectional sizes and shapes. The conduit or tube can be formed from various materials including, but not limited to, polymers, metals, ceramics, glass, composites or the like. In some embodiments, surfaces lining the airflow pathway 424 can be coated with materials to provide various desirable functional properties.
The airflow aperture 422 is generally configured to provide an input for the gas sample at the housing 420. In some embodiments the airflow aperture 422 is configured to be in fluid communication with a patient's mouth, although in some other embodiments a protective liner can be used to provide a barrier between the patient's mouth and the housing, which will be described in more detail, below.
The airflow pathway 424 generally is configured to direct the gas input at the airflow aperture 422 to the gas testing chamber 426. As such, the airflow pathway 424 generally extends from the airflow aperture 422 to the gas testing chamber 426. The airflow pathway 424 can have a cross-sectional area that is substantially the same along the length of the airflow pathway or it can vary. In some embodiments, the gas testing chamber 426 can have different interior dimensions (e.g., height, width, etc.) than the airflow pathway leading to it.
The gas testing chamber 426 defines a testing location for the gas sample. In various embodiments, the gas testing chamber 426 is configured to receive a measurement zone 442 of a disposable sensor test strip 440. Accordingly, the sensor receptacle 428 defined by the housing 420 is generally configured to removably retain the disposable sensor test strip 440 within the gas testing chamber 426. In various embodiments the sensor receptacle 428 is configured to slidably receive the disposable sensor test strip 440 that is manually inserted by a user. In some embodiments, the disposable sensor test strip 440 can be inserted with its long (or major) axis parallel to the long (or major) axis of the housing 420. However, in other embodiments, the disposable sensor test strip 440 can be inserted with its long (or major) axis positioned differently with respect to the long (or major) axis of the housing 420, such as perpendicular. Example sensor test strips will be described in more detail, below.
While
The docking station 430 is generally configured to collect data generated from testing the gas sample. The docking station 430 has a reading device 432 that can include circuitry to measure the capacitance of a plurality of graphene sensors. Aspects of circuitry to measure the capacitance of the graphene sensors is described in greater detail below. However, it will be appreciated that in some embodiments, such circuitry can all be disposed in the gas sampling device 410, can all be disposed in the docking station 430, or can be distributed with some components in the gas sampling device 410 and some components in the docking station 430. Indeed, in some cases there may not be a separate docking station and functionality attributed thereto herein can simply be integrated into the gas sampling device.
In various embodiments, the reading device 432 can also be configured to both baseline data and sample data from the disposable sensor test strip 440—where the term “baseline data” is defined as data collected before exposure of the disposable sensor test strip 440 to the gas sample or the patient or test subject and wherein the term “sample data” refers to data specific to the gas sample of the patient or test subject. In some cases the baseline data can reflect conditions of whatever gas happens to be in the testing chamber prior to obtaining a gas sample of a patient. However, in other embodiments, ambient air can purposefully be pushed through the testing chamber, and/or a particular reference gas sample of known composition can be put into the testing chamber for purposes of generating baseline data.
The docking station 430 is generally configured to be a docking location for the gas sampling device 410. The docking station 430 is generally configured to physically receive the gas sampling device 410. The docking station 430 can receive the gas sampling device 410 through a variety of structures and configurations that will be appreciated by those having ordinary skill in the art. In various embodiments the docking station 430 and the docking structure 421 of the gas sampling device 410 have a mating configuration by which the docking station 430 receives the docking structure 421 of the gas sampling device 410. In some such embodiments the docking station 430 and the docking structure 421 define an interference fit. However, in other embodiments, the docking station 430 can simply rest upon or in the docking structure 421. In some embodiments the docking station 430 and the docking structure 421 are configured to position the disposable sensor test strip 440 and the reading device 432 in sufficient proximity to accommodate transmission of data between the reading device 432 and disposable sensor test strip 440. In some embodiments the docking station and the docking structure are configured to position the disposable sensor test strip 440 and the reading device 432 within 6 cm, 5 cm, 4 cm, 3 cm, or 2 cm of each other, or even within 1 cm of each other.
The docking station 430 can have various additional components. In some embodiments the docking station 430 has a processor 436 and memory 435. The processor 436 and memory 435 can be configured to process and store data obtained from the tested gas sample. For example, the memory 435 can store baseline data locally and the processor 436 can be configured to remove collected baseline data from the tested gas data to obtain adjusted data. Such adjusted data can remove some impact of the ambient environment on the tested gas data. In another example, the processor can be configured to compare the adjusted data (or, in some embodiments the tested gas data) to known data indicative of one or more diseases. Such a comparison can be used to identify the presence of a particular disease using a comparative algorithm. In yet another example, the processor of the docking station 430 can be configured to identify a defect in the disposable sensor test strip 440. Example defects can include manufacturing defects and/or premature exposure to ambient gases. The docking station 430 can be configured to collect, save, and potentially transmit records of such defects.
The docking station 430 has networking hardware 434 in various embodiments. The networking hardware 434 can be configured to transmit data over a network to a remote system, including a cloud-based system. In some implementations the remote system can be a hospital, clinic, laboratory, or other location. In some embodiments the networking hardware 434 is configured to transmit data generated from testing the gas sample. The networking hardware 434 is configured to transmit baseline data in some embodiments. The networking hardware is configured to transmit adjusted data in some embodiments. In some embodiments the remote system analyzes the data it receives. For example, in some embodiments the remote system is configured to compare the adjusted data to known data indicative of a plurality of diseases. That comparison can identify the presence of a particular disease.
In some embodiments the docking station 430 has a user interface 438. The user interface 438 can be configured to communicate information to a user. For example, the user interface 438 can be configured to communicate an active data transmission, such as a data transmission between the docking station 430 and the gas sampling device 410 and/or between the docking station 430 and a network. In some embodiments the user interface 438 can be configured to communicate information about the current stage of the testing process, progress of the same, or what steps are next or what actions are required. For example, in some cases the user interface 438 can be configured to communicate that that the gas sampling device 410 is ready to receive a gas sample or that the docking station 430 has finished reading data from the gas sampling device 410. The user interface 438 can also be configured to communicate a defect in the sensor test strip. The user interface 438 can be configured to communicate through visual notification, audio notification, and the like. As a specific example, a flashing light can be used to indicate that the docking station 430 is transmitting data. The user interface 438 can include a light source such as an LED or similar light emitting device.
One example approach to using the system depicted in
The measurement zones 442 can include a plurality of discrete binding detectors that can include one or more analyte binding receptors bound thereto. In some embodiments, all of the analyte binding receptors within a particular discrete binding detector can be the same with respect to their analyte binding properties. In other embodiments, at least some of the analyte binding receptors within a particular zone can be different from one another with respect to their analyte binding properties. In some embodiments, each discrete binding detector can be unique. In some embodiments, discrete binding detectors that are unique can be cross-reactive in that they bind to different portions or different configurations of the same chemical compound.
The plurality of graphene varactors can include those that are specific for different volatile organic compounds. In some embodiments, the plurality of graphene varactors can detect the presence of at least 5, 10, 15, 20, 30, 40 or more different volatile organic compounds. In some embodiments, the number of different volatile organic compounds detected by the graphene varactors can be in a range wherein any of the forgoing numbers can serve as the upper or lower bound of the range provided that the upper bound is greater than the lower bound.
As referenced above, the capacitance of the graphene sensor can be measured by delivering an excitation current at a particular voltage and/or over a range of voltages. Measuring the capacitance provides data that reflects the binding status of analytes to the graphene sensor. Various measurement circuitry can be used to measure the capacitance of the graphene sensor.
Referring now to
In some embodiments, the CDC 502 can be in electrical communication with a bus device 510. The bus device 510 can include various specific components, but in some embodiments can be selected from the group consisting of an I2C or an SPI. The bus device 510 can, in turn, be in electrical communication with a controller or processor. For example, the bus device 510 can be in electrical communication with a microcontroller 512. The microcontroller 512 can, in turn, be in communication with other components of the device or system. In will be appreciated that not all of the components illustrated in
In operation, the excitation signal (an alternating voltage) is applied to the selected capacitor through the multiplexor and the electronic charge required to charge and discharge the graphene varactor is measured to determine the capacitance. The amplitude of the excitation signal is fixed by the CDC 502. The bias voltage at which the capacitance is measured is equal to the average voltage of the excitation signal. An exemplary CDC for this type of configuration includes Texas Instruments model FDC1004. The FDC1004 has an integrated multiplexor and I2C. It will be appreciated that many other types of CDCs can also be used.
In some embodiments, the graphene varactors may not be grounded. The other side of the graphene varactors can be connected to another device. For example, in some embodiments the other side of the graphene varactors can be connected to an independent excitation output of the CDC or another component. In this case, an excitation signal (again, an alternating voltage) is applied to all of the capacitors in the sensor array, and electronic charge required to charge and discharge the selected graphene varactor is measured through the multiplexor to determine the capacitance. The amplitude of the excitation signal is set by the CDC. The bias voltage at which the capacitance is measured is equal to the difference between the bias voltage at the CDC input (via the multiplexor, usually equal to VCC/2, where VCC is the supply voltage) and the average voltage of the excitation signal. Since the excitation voltage is typically centered about VCC/2 for this type of CDC, the bias voltage is typically fixed at zero volts.
Referring now to
The change in capacitance of the graphene varactor based on analyte binding depends on the excitation voltage used to measure the capacitance. Because of this, a greater amount of information can be gathered by varying the voltage of the excitation signal across a range of voltages. Various techniques can be used to achieve this. However, in some embodiments, a pair of programmable digital to analog converters with different output voltages can be used in combination with a switch in order to achieve variation in the voltage of the excitation signal.
Referring now to
In this case, the excitation signal from the CDC controls the switch between the output voltages of the two programmable Digital to Analog Converters (DACs). The programmed voltage difference between the DACs determines the excitation amplitude, providing an additional programmable scale factor to the measurement and allowing measurement of a wider range of capacitances than specified by the CDC. The bias voltage at which the capacitance is measured is equal to the difference between the bias voltage at the CDC input (via the multiplexor, usually equal to VCC/2, where VCC is the supply voltage) and the average voltage of the excitation signal, which is programmable. In some embodiments, buffer amplifiers and/or bypass capacitance can be used at the DAC outputs to maintain stable voltages during switching. Many different ranges of DC bias voltages can be used. In some embodiments, the range of DC bias voltages can be from −3 V to 3 V, or from −1 V to 1 V, or from −0.5 V to 0.5 V.
Many different aspects can be calculated based on the capacitance data. For example, aspects that can be calculated include maximum slope of capacitance to voltage, change in maximum slope of capacitance to voltage over a baseline value, minimum slope of capacitance to voltage, change in minimum slope of capacitance to voltage over a baseline value, minimum capacitance, change in minimum capacitance over a baseline value, voltage at minimum capacitance (Dirac point), change in voltage at minimum capacitance, maximum capacitance, change in maximum capacitance, ratio of maximum capacitance to minimum capacitance, response time constants, and ratios of any of the foregoing between different graphene sensors and particularly between different graphene sensors having specificity for different analytes.
The above calculated aspects can be used for various diagnostic purposes. In some cases, the above calculated aspects can be indicative of the identity and/or concentrations of specific volatile organic components of a gas sample. As such, each of the calculated values above can serve as a distinct piece of data that forms part of a pattern for a given patient and/or given gas sample. As also described elsewhere herein, the pattern can then be matched against preexisting patterns, or patterns identified in real-time, derived from large, stored data sets through techniques such as machine learning or other techniques, wherein such patterns are determined to be characteristic of various conditions or disease states. The above calculated aspects can also be put to other purposes, diagnostic and otherwise.
In some cases calculations, such as those described above, can be performed by a controller circuit. The controller circuit can be configured to receive an electrical signal reflecting the capacitance of the graphene varactors. In some embodiments, the controller circuit can include a microcontroller to perform these calculations. In some cases the controller circuit can include a microprocessor in electrical communication with the measurement circuit. The microprocessor system can include components such as an address bus, a data bus, a control bus, a clock, a CPU, a processing device, an address decoder, RAM, ROM and the like. In some cases the controller circuit can include a calculation circuit (such as an application specific integrated circuit—ASIC) in electrical communication with the measurement circuit.
In addition, in some cases the system can include a nonvolatile memory where sensitivity calibration information for the particular sensor is stored. By way of example, the sensor could be tested in a production facility, where its sensitivity to various analytes such as VOC's can be determined and then stored on an EPROM or similar component. In addition or alternatively, sensitivity calibration information can be stored in a central database and referenced with a sensor serial number when patient data is sent to a central location for analysis and diagnosis. These components can be included with any of the pieces of hardware described herein.
In some embodiments herein, components can be configured to communicate over a network, such as the internet or a similar network. In various embodiments, a central storage and data processing facility can be included. In some embodiments, data gathered from sensors in the presence of the patient (local) can be sent to the central processing facility (remote) via the internet or a similar network, and the pattern from the particular patient being evaluated can be compared to those of thousands or millions of other patients, many of whom have been previously diagnosed with various conditions and wherein such condition data has been stored. Pattern matching algorithms can be used to find other patients or classes of patients (for example disease or condition specific classes) to which the current patient's pattern is most similar. Each class of patients can include a predetermined likelihood of having a given condition or disease state. In this manner, after pattern matching a likelihood of having a given condition or disease state can be provided back across the data network to the facility where the patient is currently at.
Methods
Embodiments herein can include various methods. Exemplary methods can include any of the approaches and/or operations described herein. In an embodiment, a method of measuring analyte presence on a graphene varactor is included. The method can include measuring a capacitance of the graphene varactor over a range of DC bias voltages, comparing the measured capacitance at one or more DC bias voltages to one or more corresponding baseline capacitance values and determining the presence or absence of an analyte based on the comparison.
In some embodiments, the method can further include determining one or more aspects including, but not limited to, maximum slope of capacitance to voltage, change in maximum slope of capacitance to voltage over a baseline value, minimum slope of capacitance to voltage, change in minimum slope of capacitance to voltage over a baseline value, minimum capacitance, change in minimum capacitance over a baseline value and voltage at minimum capacitance (Dirac point), change in voltage at minimum capacitance, maximum capacitance, change in maximum capacitance, ratio of maximum capacitance to minimum capacitance, response time constants, and ratios of any of the foregoing between different graphene sensors and particularly between different graphene sensors having specificity for different analytes.
In some embodiments, the method can include forming a capacitance to voltage curve from the measured capacitance of the graphene varactor over the range of DC bias voltages. In some embodiments, the method can include comparing the formed capacitance to voltage curve with a baseline capacitance to voltage curve. In some embodiments, the method can include distinguishing between different analytes binding to the graphene varactor. In some embodiments the method can further include measuring a capacitance of the graphene varactor over a range of DC bias voltages. In some embodiments, the range of DC bias voltages can be from −3 V to 3 V.
In some embodiments, the patient can be prompted to take a breath or gas test (where the test could be performed either in a non-clinical setting such as their home or where such a prompt could cause them to come to a clinical setting to take the test).
In some embodiments, a pattern including such things as sleep patterns (e.g. wearable, implant or non-contact in-home sensor), physiological data (autonomic tone measures), body weight (such as weight automatically measured by a mat in the house), activity levels (e.g. mobile device, wearable, implant or non-contact in-home sensor), etc. can be assessed, such as using an algorithm, and if the results of those factors so indicate, then the system can inform the user that they should administer or get a breath or gas test to detect early signs of heart failure decompensation. If a positive result, or data trends are beyond a normal range for the individual patient, then the system can inform the patient to seek medical care for early intervention.
In some embodiments, a pattern including things such as sleep patterns, autonomic tone, respiratory rate, respiratory sounds, activity levels, etc., can be used to recommend to the user that they should administer a breath test (or come to a clinic to get a breath test) to detect early signs of a COPD exacerbation or repeat exacerbation. If a positive result, or data trends beyond normal range for the individual patient, seek medical care and/or use prescribed pharmaceutical (e.g. bronchodilators, corticosteroids, etc.) for early intervention.
Beyond, heart failure decompensation and COPD, such patterns and prompts to the patient to get a breath test can also be used for diabetes management and inflammatory bowel diseases (also including data regarding dietary intake, autonomic tone, etc. in the pattern) to detect early signs of a flare-up.
A graphene varactor was manufactured consistent with that described in U.S. Publ. Appl. No. 2014/0145735.
A baseline capacitance to voltage curve was established by measuring capacitance over a range of excitation voltages while flushing the sensor with nitrogen gas using an LCR meter. The DC bias voltage ranged from −0.5 volts to 0.5 volts. Using the same LCR meter, capacitance values over the same bias voltage range were also measured while flushing the sensor with a combination of nitrogen gas and octanol vapor. The total flow rate was 0.5 liters per minute in each experiment, octanol concentration was approximately 3.6 parts per million in nitrogen, sensors were exposed to the nitrogen gas and octanol vapor mixture for approximately 5 minutes before measurement for equilibration, the AC excitation signal had amplitude 50 mV and frequency 500 kHz.
As shown in
A graphene varactor was prepared as described in Example 1. A baseline capacitance to voltage curve was established by measuring capacitance over a range of excitation voltages using an LCR meter as described above in Example 1. The DC bias voltage ranged from −1 volt to 1 volt. Using the same LCR meter, capacitance values over the same bias voltage range were also measured while flushing the sensor with a combination of nitrogen gas and acetone vapor. Details were the same as descried above in Example 1, except that the acetone concentration was approximately 25,000 parts per million.
As shown in
A graphene varactor was prepared as described in Example 1. The graphene was then functionalized with pyrene-acetic acid by soaking the varactor in a 1 mM solution of pyrene acetic-acid in ethanol for 14 hours.
A baseline capacitance to voltage curve was established by measuring capacitance over a range of excitation voltages using an LCR meter as described above in Example 1. The DC bias voltage ranged from −1 volt to 1 volt. Using the same LCR meter, capacitance values over the same bias voltage range were also measured while flushing the sensor with: 1.) a combination of nitrogen gas and gaseous acetone, 1.) a combination of nitrogen gas and gaseous octane, and 3.) a combination of nitrogen gas and gaseous octanol.
As shown in
It should be noted that, as used in this specification and the appended claims, the singular forms “a,” “an,” and “the” include plural referents unless the content clearly dictates otherwise. Thus, for example, reference to a composition containing “a compound” includes a mixture of two or more compounds. It should also be noted that the term “or” is generally employed in its sense including “and/or” unless the content clearly dictates otherwise.
It should also be noted that, as used in this specification and the appended claims, the phrase “configured” describes a system, apparatus, or other structure that is constructed or configured to perform a particular task or adopt a particular configuration to. The phrase “configured” can be used interchangeably with other similar phrases such as arranged and configured, constructed and arranged, constructed, manufactured and arranged, and the like. “Circuitry” can include both hardwired circuitry for execution of particular operations as well as processors that are programmed to execute instructions to provide the same functionality.
All publications and patent applications in this specification are indicative of the level of ordinary skill in the art to which this specification pertains. All publications and patent applications are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated by reference.
Aspects have been described with reference to various specific and preferred embodiments and techniques. However, it should be understood that many variations and modifications may be made while remaining within the spirit and scope herein. As such, the embodiments described herein are not intended to be exhaustive or to limit the scope to the precise forms disclosed herein. Rather, the embodiments are chosen and described so that others skilled in the art can appreciate and understand the principles and practices.
This application is a continuation of U.S. application Ser. No. 16/037,218, filed Jul. 17, 2018, which claims the benefit of U.S. Provisional Application No. 62/533,916, filed Jul. 18, 2017, the contents of which are herein incorporated by reference in their entirety.
Number | Name | Date | Kind |
---|---|---|---|
3661528 | Falk | May 1972 | A |
3952730 | Key | Apr 1976 | A |
3981297 | Dunn et al. | Sep 1976 | A |
4820011 | Umegaki et al. | Apr 1989 | A |
4901727 | Goodwin | Feb 1990 | A |
5174290 | Fiddian-Green | Dec 1992 | A |
5186172 | Fiddian-Green | Feb 1993 | A |
5357971 | Sheehan et al. | Oct 1994 | A |
5423320 | Salzman et al. | Jun 1995 | A |
5704368 | Asano et al. | Jan 1998 | A |
5834626 | De Castro et al. | Nov 1998 | A |
5928155 | Eggers et al. | Jul 1999 | A |
6006121 | Vantrappen et al. | Dec 1999 | A |
6029076 | Fiddian-Greene et al. | Feb 2000 | A |
6085576 | Sunshine | Jul 2000 | A |
6149624 | McShane | Nov 2000 | A |
6170318 | Lewis | Jan 2001 | B1 |
6192168 | Feldstein et al. | Feb 2001 | B1 |
6238339 | Fiddian-Greene et al. | May 2001 | B1 |
6248078 | Risby et al. | Jun 2001 | B1 |
6312390 | Phillips et al. | Nov 2001 | B1 |
6480734 | Zhang et al. | Nov 2002 | B1 |
6599253 | Baum et al. | Jul 2003 | B1 |
6615066 | Huyberechts et al. | Sep 2003 | B2 |
6712770 | Lin et al. | Mar 2004 | B2 |
6726637 | Phillips et al. | Apr 2004 | B2 |
6733464 | Olbrich et al. | May 2004 | B2 |
6781690 | Armstrong et al. | Aug 2004 | B2 |
6955652 | Baum et al. | Oct 2005 | B1 |
6978182 | Mazar et al. | Dec 2005 | B2 |
7032431 | Baum et al. | Apr 2006 | B2 |
7123359 | Armstrong et al. | Oct 2006 | B2 |
7177686 | Turcott et al. | Feb 2007 | B1 |
7426848 | Li et al. | Sep 2008 | B1 |
7459312 | Chen et al. | Dec 2008 | B2 |
7704214 | Meixner et al. | Apr 2010 | B2 |
7809441 | Kane et al. | Oct 2010 | B2 |
7871572 | Yang et al. | Jan 2011 | B2 |
7955562 | Hong et al. | Jun 2011 | B2 |
7972277 | Oki et al. | Jul 2011 | B2 |
7988917 | Roesicke et al. | Aug 2011 | B2 |
7992422 | Leddy et al. | Aug 2011 | B2 |
8043860 | Leznoff et al. | Oct 2011 | B2 |
8052933 | Schirmer et al. | Nov 2011 | B2 |
8080206 | Leddy et al. | Dec 2011 | B2 |
8124419 | Grigorian et al. | Feb 2012 | B2 |
8153439 | Zamborini et al. | Apr 2012 | B2 |
8154093 | Passmore et al. | Apr 2012 | B2 |
8157730 | Tucker et al. | Apr 2012 | B2 |
8222041 | Pearton et al. | Jul 2012 | B2 |
8244355 | Bennett et al. | Aug 2012 | B2 |
8294135 | Lebedev et al. | Oct 2012 | B2 |
8366630 | Haick et al. | Feb 2013 | B2 |
8479731 | Heinonen et al. | Jul 2013 | B2 |
8481324 | Nakhoul et al. | Jul 2013 | B2 |
8494606 | Debreczeny et al. | Jul 2013 | B2 |
8529459 | Stahl et al. | Sep 2013 | B2 |
8581262 | Pan et al. | Nov 2013 | B2 |
8597953 | Haick et al. | Dec 2013 | B2 |
8747325 | Bacal et al. | Jun 2014 | B2 |
8828713 | Ren et al. | Sep 2014 | B2 |
8835984 | Ren et al. | Sep 2014 | B2 |
8848189 | Goldshtein et al. | Sep 2014 | B2 |
8951473 | Wang et al. | Feb 2015 | B2 |
8955367 | Gouma et al. | Feb 2015 | B2 |
8961830 | Reynolds et al. | Feb 2015 | B2 |
9011779 | Anglin, Jr. et al. | Apr 2015 | B1 |
9029168 | Mannoor et al. | May 2015 | B2 |
9034170 | Blackburn et al. | May 2015 | B2 |
9085715 | Berthelot et al. | Jul 2015 | B2 |
9103775 | Bradley et al. | Aug 2015 | B2 |
9138169 | Beard | Sep 2015 | B2 |
9147398 | White et al. | Sep 2015 | B2 |
9147851 | Bartsch et al. | Sep 2015 | B1 |
9267908 | Wang et al. | Feb 2016 | B2 |
9299238 | Ahmad et al. | Mar 2016 | B1 |
9315848 | Haick et al. | Apr 2016 | B2 |
9316637 | Ren et al. | Apr 2016 | B2 |
9324825 | Ravesi et al. | Apr 2016 | B2 |
9366664 | Anglin, Jr. et al. | Jun 2016 | B2 |
9410040 | Li et al. | Aug 2016 | B2 |
9513244 | Koester | Dec 2016 | B2 |
9528979 | Haick et al. | Dec 2016 | B2 |
9618476 | Goldsmith | Apr 2017 | B2 |
9638169 | Obrecht | May 2017 | B2 |
9642577 | Li et al. | May 2017 | B1 |
9671392 | Jeppsen et al. | Jun 2017 | B2 |
9689836 | Makaram et al. | Jun 2017 | B2 |
9696311 | Haick et al. | Jul 2017 | B2 |
9763600 | Van Kesteren et al. | Sep 2017 | B2 |
9765395 | Goldsmith | Sep 2017 | B2 |
9775241 | Walczak et al. | Sep 2017 | B2 |
9859034 | Sjong | Jan 2018 | B2 |
9936897 | Carlson et al. | Apr 2018 | B2 |
9977011 | Beck et al. | May 2018 | B2 |
10034621 | Wondka et al. | Jul 2018 | B2 |
10046323 | Bos | Aug 2018 | B2 |
10307080 | Ssenyange et al. | Jun 2019 | B2 |
10493276 | Moffitt et al. | Dec 2019 | B2 |
10543035 | Sutermeister et al. | Jan 2020 | B2 |
10770182 | Sherwood et al. | Sep 2020 | B2 |
10852264 | Kelly et al. | Dec 2020 | B2 |
11079371 | Zhen et al. | Aug 2021 | B2 |
11085921 | Livache et al. | Aug 2021 | B2 |
11172846 | Sherwood et al. | Nov 2021 | B2 |
11191457 | Sherwood et al. | Dec 2021 | B2 |
11262354 | Sherwood | Mar 2022 | B2 |
11662325 | Sherwood et al. | May 2023 | B2 |
20020123749 | Jain et al. | Sep 2002 | A1 |
20020142477 | Lewis et al. | Oct 2002 | A1 |
20030051733 | Kotmel et al. | Mar 2003 | A1 |
20040039295 | Olbrich et al. | Feb 2004 | A1 |
20060130557 | Leddy et al. | Jun 2006 | A1 |
20060263255 | Han et al. | Nov 2006 | A1 |
20060270940 | Tsukashima et al. | Nov 2006 | A1 |
20070048181 | Chang et al. | Mar 2007 | A1 |
20070083094 | Colburn et al. | Apr 2007 | A1 |
20070167853 | Melker et al. | Jul 2007 | A1 |
20070229818 | Duan et al. | Oct 2007 | A1 |
20070265509 | Burch et al. | Nov 2007 | A1 |
20080021339 | Gabriel et al. | Jan 2008 | A1 |
20080038154 | Longbottom et al. | Feb 2008 | A1 |
20080052122 | Iliff | Feb 2008 | A1 |
20080146890 | LeBoeuf et al. | Jun 2008 | A1 |
20080161709 | Bradley | Jul 2008 | A1 |
20080183910 | Natoli et al. | Jul 2008 | A1 |
20080228098 | Popov et al. | Sep 2008 | A1 |
20080317636 | Brahim et al. | Dec 2008 | A1 |
20090054799 | Vrtis et al. | Feb 2009 | A1 |
20090104435 | Hutchison et al. | Apr 2009 | A1 |
20090112115 | Huang et al. | Apr 2009 | A1 |
20090230300 | Trevejo et al. | Sep 2009 | A1 |
20100024533 | Kimura et al. | Feb 2010 | A1 |
20100056892 | Ben-Barak et al. | Mar 2010 | A1 |
20100085067 | Gabriel et al. | Apr 2010 | A1 |
20100116021 | O'Brien | May 2010 | A1 |
20100137733 | Wang et al. | Jun 2010 | A1 |
20100147303 | Jafari et al. | Jun 2010 | A1 |
20100188069 | Ren et al. | Jul 2010 | A1 |
20100198521 | Haick et al. | Aug 2010 | A1 |
20100216175 | Melker et al. | Aug 2010 | A1 |
20100268479 | Potyrailo et al. | Oct 2010 | A1 |
20100273665 | Haick et al. | Oct 2010 | A1 |
20110015872 | Haick et al. | Jan 2011 | A1 |
20110017587 | Zhamu et al. | Jan 2011 | A1 |
20110059476 | Shin et al. | Mar 2011 | A1 |
20110143962 | Chaubron et al. | Jun 2011 | A1 |
20110201956 | Alferness et al. | Aug 2011 | A1 |
20110269632 | Haick et al. | Nov 2011 | A1 |
20110283770 | Hok et al. | Nov 2011 | A1 |
20120100636 | Johal et al. | Apr 2012 | A1 |
20120111093 | Brahim et al. | May 2012 | A1 |
20120126111 | Chaubron et al. | May 2012 | A1 |
20120156099 | Zhong et al. | Jun 2012 | A1 |
20120166095 | Potyrailo et al. | Jun 2012 | A1 |
20120203081 | LeBoeuf et al. | Aug 2012 | A1 |
20120226111 | LeBoeuf et al. | Sep 2012 | A1 |
20120226112 | LeBoeuf et al. | Sep 2012 | A1 |
20120245434 | Haick et al. | Sep 2012 | A1 |
20120245854 | Haick et al. | Sep 2012 | A1 |
20120277794 | Kountotsis et al. | Nov 2012 | A1 |
20120306802 | McCracken | Dec 2012 | A1 |
20120326092 | Haick et al. | Dec 2012 | A1 |
20130034190 | Tan et al. | Feb 2013 | A1 |
20130034910 | Haick et al. | Feb 2013 | A1 |
20130059758 | Haick et al. | Mar 2013 | A1 |
20130100067 | Dews | Apr 2013 | A1 |
20130102018 | Schentag et al. | Apr 2013 | A1 |
20130143247 | Haick et al. | Jun 2013 | A1 |
20130150261 | Haick et al. | Jun 2013 | A1 |
20130165810 | Saatchi et al. | Jun 2013 | A1 |
20130171733 | Haick et al. | Jul 2013 | A1 |
20130178756 | Suzuki et al. | Jul 2013 | A1 |
20130211207 | Joseph et al. | Aug 2013 | A1 |
20130211852 | Roizen et al. | Aug 2013 | A1 |
20130224761 | Imberty et al. | Aug 2013 | A1 |
20130236981 | Haick et al. | Sep 2013 | A1 |
20130253358 | Phillips et al. | Sep 2013 | A1 |
20130267862 | Jaffe et al. | Oct 2013 | A1 |
20130289368 | Covington et al. | Oct 2013 | A1 |
20130331723 | Hernandez-Silveira et al. | Dec 2013 | A1 |
20130334579 | Accardi et al. | Dec 2013 | A1 |
20140018691 | Mcneill et al. | Jan 2014 | A1 |
20140041436 | Knott et al. | Feb 2014 | A1 |
20140051956 | Dalene et al. | Feb 2014 | A1 |
20140094669 | Jaffe et al. | Apr 2014 | A1 |
20140122515 | Lee et al. | May 2014 | A1 |
20140145735 | Koester | May 2014 | A1 |
20140171817 | Blanch et al. | Jun 2014 | A1 |
20140194703 | Wondka et al. | Jul 2014 | A1 |
20140275597 | Zhang et al. | Sep 2014 | A1 |
20140275854 | Venkatraman et al. | Sep 2014 | A1 |
20140276168 | Satya et al. | Sep 2014 | A1 |
20140294675 | Melker et al. | Oct 2014 | A1 |
20140318535 | Bullock et al. | Oct 2014 | A1 |
20140378790 | Cohen | Dec 2014 | A1 |
20150013429 | Atkin et al. | Jan 2015 | A1 |
20150038378 | Cheng et al. | Feb 2015 | A1 |
20150044710 | Dasgupta et al. | Feb 2015 | A1 |
20150065365 | Ahmad | Mar 2015 | A1 |
20150164373 | Davis et al. | Jun 2015 | A1 |
20150196251 | Outwater et al. | Jul 2015 | A1 |
20150250408 | Ssenyange et al. | Sep 2015 | A1 |
20150257676 | Fries | Sep 2015 | A1 |
20150265184 | Wondka et al. | Sep 2015 | A1 |
20150295562 | Agarwal et al. | Oct 2015 | A1 |
20150298115 | Campidelli et al. | Oct 2015 | A1 |
20150301021 | Haick et al. | Oct 2015 | A1 |
20150307936 | Goldsmith | Oct 2015 | A1 |
20150309018 | Goldsmith | Oct 2015 | A1 |
20150320338 | Kane et al. | Nov 2015 | A1 |
20150335266 | Cormier | Nov 2015 | A1 |
20150335267 | Cormier et al. | Nov 2015 | A1 |
20150338340 | Jiang et al. | Nov 2015 | A1 |
20150338390 | Anglin et al. | Nov 2015 | A1 |
20150351699 | Addison et al. | Dec 2015 | A1 |
20160025675 | Goldsmith | Jan 2016 | A1 |
20160054312 | Goldsmith | Feb 2016 | A1 |
20160089089 | Kakkar et al. | Mar 2016 | A1 |
20160093806 | Turchanin | Mar 2016 | A1 |
20160109440 | Sherwood et al. | Apr 2016 | A1 |
20160116431 | Accardi et al. | Apr 2016 | A1 |
20160150995 | Ratto et al. | Jun 2016 | A1 |
20160157752 | Cho et al. | Jun 2016 | A1 |
20160192861 | Gedeon et al. | Jul 2016 | A1 |
20160231309 | Ahmad et al. | Aug 2016 | A1 |
20160289769 | Schwartz et al. | Oct 2016 | A1 |
20160334381 | King-smith et al. | Nov 2016 | A1 |
20160334386 | Anglin et al. | Nov 2016 | A1 |
20160356741 | Makaram et al. | Dec 2016 | A1 |
20160370337 | Blackley | Dec 2016 | A1 |
20170014043 | McDonnell | Jan 2017 | A1 |
20170042435 | Vermeulen et al. | Feb 2017 | A1 |
20170053068 | Pillai et al. | Feb 2017 | A1 |
20170067888 | Taslim et al. | Mar 2017 | A1 |
20170082566 | Koester | Mar 2017 | A1 |
20170212116 | Braga et al. | Jul 2017 | A1 |
20170227491 | Johnson et al. | Aug 2017 | A1 |
20170307562 | Goldsmith | Oct 2017 | A1 |
20170307576 | Anglin, Jr. | Oct 2017 | A1 |
20170360337 | Sherwood et al. | Dec 2017 | A1 |
20170361599 | Lerner et al. | Dec 2017 | A1 |
20170365474 | Pan et al. | Dec 2017 | A1 |
20170365477 | Pan et al. | Dec 2017 | A1 |
20170365562 | Pan et al. | Dec 2017 | A1 |
20180035932 | Massova | Feb 2018 | A1 |
20180037952 | Goldsmith | Feb 2018 | A1 |
20180037985 | Myers et al. | Feb 2018 | A1 |
20180110444 | Sherwood et al. | Apr 2018 | A1 |
20180328841 | Graham et al. | Nov 2018 | A1 |
20180336970 | Sherwood et al. | Nov 2018 | A1 |
20190025237 | Kelly et al. | Jan 2019 | A1 |
20190178837 | Xu et al. | Jun 2019 | A1 |
20190254538 | Erdman et al. | Aug 2019 | A1 |
20190257825 | Zhen et al. | Aug 2019 | A1 |
20190286866 | Gurt | Sep 2019 | A1 |
20190331661 | Zhen et al. | Oct 2019 | A1 |
20200166435 | Sherwood et al. | May 2020 | A1 |
20200191737 | Sherwood et al. | Jun 2020 | A1 |
20210057526 | Zhen et al. | Feb 2021 | A1 |
20210072208 | Sherwood et al. | Mar 2021 | A1 |
20210341409 | Rognrud et al. | Nov 2021 | A1 |
20220334075 | Koester et al. | Oct 2022 | A1 |
Number | Date | Country |
---|---|---|
1301342 | Jun 2001 | CN |
102183557 | Sep 2011 | CN |
102770069 | Nov 2012 | CN |
102941042 | Feb 2013 | CN |
103332678 | Oct 2013 | CN |
103814294 | May 2014 | CN |
103950920 | Jul 2014 | CN |
104914138 | Sep 2015 | CN |
103852505 | Nov 2015 | CN |
103877574 | Jan 2016 | CN |
105445335 | Mar 2016 | CN |
105527321 | Apr 2016 | CN |
105688995 | Jun 2016 | CN |
106152924 | Nov 2016 | CN |
107180706 | Sep 2017 | CN |
109270130 | Jan 2019 | CN |
109310326 | Feb 2019 | CN |
109862829 | Jun 2019 | CN |
110769742 | Feb 2020 | CN |
107076693 | Sep 2020 | CN |
1764153 | Mar 2007 | EP |
1806414 | Jul 2007 | EP |
3093653 | Nov 2016 | EP |
3210007 | Aug 2017 | EP |
3439544 | Feb 2019 | EP |
3528703 | Aug 2019 | EP |
3624678 | Mar 2020 | EP |
3431977 | Dec 2020 | EP |
201627028955 | Oct 2016 | IN |
H07507943 | Sep 1995 | JP |
H11174051 | Jul 1999 | JP |
2005514081 | May 2005 | JP |
2008516209 | May 2008 | JP |
2009244074 | Oct 2009 | JP |
2011102747 | May 2011 | JP |
2011523363 | Aug 2011 | JP |
2012122814 | Jun 2012 | JP |
2012517276 | Aug 2012 | JP |
2016022415 | Feb 2016 | JP |
2016511456 | Apr 2016 | JP |
2016122249 | Jul 2016 | JP |
2017123912 | Jul 2017 | JP |
2019020415 | Feb 2019 | JP |
2019527365 | Sep 2019 | JP |
2019536013 | Dec 2019 | JP |
2020521128 | Jul 2020 | JP |
20170057001 | May 2017 | KR |
101797737 | Nov 2017 | KR |
9325142 | Dec 1993 | WO |
9947905 | Sep 1999 | WO |
2001070114 | Sep 2001 | WO |
2008083285 | Jul 2008 | WO |
2008088780 | Jul 2008 | WO |
2009020647 | Feb 2009 | WO |
2009135070 | Nov 2009 | WO |
2011109736 | Sep 2011 | WO |
2012135565 | Oct 2012 | WO |
2012145247 | Oct 2012 | WO |
2013095730 | Jun 2013 | WO |
2013189502 | Dec 2013 | WO |
2014064740 | May 2014 | WO |
2015134895 | Sep 2015 | WO |
2015179623 | Nov 2015 | WO |
2015191558 | Dec 2015 | WO |
2016064740 | Apr 2016 | WO |
2016105464 | Jun 2016 | WO |
2016145300 | Sep 2016 | WO |
2017066583 | Apr 2017 | WO |
2017095922 | Jun 2017 | WO |
2017218464 | Dec 2017 | WO |
2018053932 | Mar 2018 | WO |
2018075731 | Apr 2018 | WO |
2018213564 | Nov 2018 | WO |
2020102880 | May 2020 | WO |
2020112825 | Jun 2020 | WO |
2020131567 | Jun 2020 | WO |
2021222489 | Nov 2021 | WO |
Entry |
---|
“Extended European Search Report,” for European Patent Application No. 20214733.6 dated Apr. 21, 2021 (11 pages). |
“Final Office Action,” for U.S. Appl. No. 15/621,103 dated Apr. 22, 2021 (20 pages). |
“Non-Final Office Action,” for U.S. Appl. No. 14/883,895 dated May 20, 2021 (34 pages). |
“Non-Final Office Action,” for U.S. Appl. No. 15/787,985 dated Apr. 16, 2021 (16 pages). |
Zhang, Xu et al., “A Wide Measurement Range and Fast Update Rate Integrated Interface for Capacitive Sensors Array,” IEEE Transactions on Circuits and Systems -1: Regular Papers, Vo. 61, No. 1, Jan. 2014, pp. 2-11 (10 pages). |
“International Preliminary Report on Patentability,” for PCT Application No. PCT/US2019/063324 dated Jun. 10, 2021 (10 pages). |
“Office Action,” for Chinese Patent Application No. 201780065376.2 dated Apr. 27, 2021 (10 pages) with English Summary. |
“Response to Final Rejection,” dated Apr. 22, 2021 for U.S. Appl. No. 15/621,103, submitted via EFS-Web on Jun. 22, 2021, 13 pages. |
“Response to Non-Final Rejection,” dated Apr. 16, 2021 for U.S. Appl. No. 15/787,985, submitted via EFS-Web on Jun. 22, 2021, 11 pages. |
“Second Office Action,” for Chinese Patent Application No. 201780030595.7 dated Jun. 17, 2021 (8 pages), with English Summary. |
Office Action for Japanese Patent Application No. 2019-520955 dated Feb. 9, 2021 (11 pages) with English Translation. |
Response to Communication Pursuant to Article 94(3) EPC for European Patent Application No. 18731579.1 filed Mar. 15, 2021 (12 pages). |
“International Preliminary Report on Patentability,” for PCT Application No. PCT/US2019/065981 dated Jul. 1, 2021 (8 pages). |
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2021/026778 dated Aug. 3, 2021 (11 pages). |
“New Summons to Attend Oral Proceedings,” for European Patent Application No. 18731579.1 dated Jul. 12, 2021 (6 pages). |
“Notice of Allowance,” for U.S. Appl. No. 15/621,103 dated Aug. 3, 2021 (18 pages). |
“Notice of Allowance,” for U.S. Appl. No. 15/787,985 dated Jul. 15, 2021 (14 pages). |
“Response to Final Rejection,” dated Apr. 22, 2021 and the Advisory Action dated Jul. 8, 2021 for U.S. Appl. No. 15/621,103, submitted via EFS-Web on Jul. 12, 2021, 13 pages. |
“Summons to attend oral proceedings pursuant to Rule 115(1) EPC,” for European Patent Application No. 18731579.1 dated Jul. 1, 2021 (6 pages). |
Planz, B., et al. “The role of urinary cytology for detection of bladder cancer,” EJSO (2005) 21, 304-308 (5 pages). |
Ramakumar, Sanjay, et al. “Comparison of Screening Methods in the Detection of Bladder Cancer,” The Journal of Urology vol. 161, 388-394, Feb. 1999 (7 pages). |
Arasaradnam, R. P. et al., “Review Article: Next Generation Diagnostic Modalities in Gastroenterology—Gas Phase Volatile compound biomarker detection,” Alimentary Pharmacology and Therapeutics 2014; 39: 780-789 (10 pages). |
Bhadra, Sharmista et al., “Non-destructive detection of fish spoilage using a wireless basic volatile sensor,” Talanta, vol. 134, Dec. 25, 2014 pp. 718-723 (6 pages). |
Boots, Agnes W. et al., “The Versatile Use of Exhaled Volatile Organic Compounds in Human Health and Disease,” J. Breath Res. 6 (2012) 027108 (21 pages). |
Chamberlain li, Richard V. et al., “Electrostatically-induced Inclusion of Anions in Cyclodextrin Monolayers on Electrodes,” Langmuir 2000, 1388-1396 (9 pages). |
Deen, David A. et al., “Graphene-Based Quantum Capacitance Wireless Vapor Sensors,” IEEE Sensors Journal, vol. 14, No. 5, May 2014, pp. 1459-1466 (8 pages). |
Di Natale, Corrado et al., “Lung Cancer Identification by the Analysis of Breath by Means of an Array of Non-Selective Gas Sensors,” Biosensors and Bioelectronics 18 (2003) 1209-1218 (10 pages). |
Droscher, S. et al., “Quantum Capacitance and Density of States of Graphene,” Phys. Scr. T146 (2012) 014009, pp. 1-5 (5 pages). |
Ebrish, M. A. et al., “Dielectric Thickness Dependence of Quantum Capacitance in Graphene Varactors with Local Metal Back Gates,” Device Research Conference, 2012 (2 pages). |
Ebrish, M. A. et al., “Operation of Multi-Finger Graphene Quantum Capacitance Varactors using Planarized Local Bottom Gate Electrodes,” Applied Physics Letters, vol. 100, No. 14, Apr. 2012 (4 pages). |
Ebrish, Mona A. et al., “Effect of Noncovalent Basal Plane Functionalization of the Quantum Capacitance in Graphene,” ACS Appl. Mater. Interfaces 2014, 6, 10296-10303 (8 pages). |
“European Search Report,” for Dutch Patent Application No. 2019492 dated Apr. 12, 2018 (10 pages). |
“Fdc1004 4-Channel Capacitance-to-Digital Converter for Capacitive Sensing Solutions,” Data Sheet SNOSCY5B Texas Instruments Aug. 2014—Revised 2015 (24 pages). |
“Fdc1004evm User Guide,” Literature No. SNAU163C, Texas Instruments August 2014—Revised Oct. 2016 (46 pages). |
File History for European Patent Application No. 15790739.5 downloaded Jan. 26, 2021 (238 pages). |
File History for European Patent Application No. 17733246.7 downloaded Jan. 26, 2021 (132 pages). |
File History for European Patent Application No. 17794832.0 downloaded Jan. 26, 2021 (152 pages). |
File History for European Patent Application No. 18731579.1 downloaded Jan. 26, 2021 (254 pages). |
File History for European Patent Application No. 18180455.0 downloaded Jan. 26, 2021 (351 pages). |
File History for U.S. Appl. No. 14/883,895 downloaded Jan. 26, 2021 (513 pages). |
File History for U.S. Appl. No. 15/621,103 downloaded Jan. 26, 2021 (419 pages). |
File History for U.S. Appl. No. 15/787,985 downloaded Jan. 26, 2021 (368 pages). |
File History for U.S. Appl. No. 15/982,506 downloaded Jan. 26, 2021 (281 pages). |
File History for U.S. Appl. No. 16/037,218 downloaded Jan. 26, 2021 (278 pages). |
“First Office Action,” for Chinese Patent Application No. 201580056417.2 dated Feb. 11, 2019 (13 pages) with English summary. |
“First Office Action,” for Chinese Patent Application No. 201780030595.7 dated Nov. 2, 2020 (12 pages) with English Summary. |
Fisher, James P. et al., “Central Sympathetic Overactivity: Maladies and Mechanisms,” Autonomic Neuroscience 148.1 (2009): 5-15 (11 pages). |
Georgakilas, Vasilios et al., “Functionalization of Graphene: Covalent and Non-Covalent Approaches, Derivatives and Applications,” Chemical Reviews, 2012, 14:112(11), pp. 6156-6214. |
Georgakilas, Vasilios et al., “Noncovalent Functionalization of Graphene and Graphene Oxide for Energy Materials, Biosensing, Catalytic, and Biomedical Applications,” Chem. Rev. 2016, 116, 5464-5519 (56 pages). |
Guo, Yujing et al., “Cyclodextrin Functionalized Graphene Nanosheets with High Supramolecular Recognition Capability: synthesis and Host-Guest Inclusion for Enhanced Electrochemical Performance,” ACS Nano, 2010, abstract only (2 pages). |
Hu, Yuhai et al., “Chemically Functionalized Graphene and Their Applications in Electrochemical Energy Conversion and Storage,” Advances in Graphene Science, Chapter 7, 2013, pp. 161-190 (30 pages). |
“International Preliminary Report on Patentability,” for PCT Application No. PCT/US2015/056243 dated May 4, 2017 (8 pages). |
“International Preliminary Report on Patentability,” for PCT Application No. PCT/US2017/057318 dated May 2, 2019 (11 pages). |
“International Preliminary Report on Patentability,” for PCT Application No. PCT/US2018/033166 dated Nov. 28, 2019 (8 pages). |
“International Preliminary Report on Patentability,” for PCT Application No. PCT/US2018/037144 dated Dec. 27, 2018 (7 pages). |
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2015/056243, dated Jan. 26, 2016 (12 pages). |
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2017/037144 dated Oct. 6, 2017 (11 pages). |
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2017/057318 dated Feb. 6, 2018 (14 pages). |
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2018/033166 dated Oct. 2, 2018 (12 pages). |
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2019/063324 dated Mar. 27, 2020 (17 pages). |
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2019/065981 dated Mar. 16, 2020 (14 pages). |
Koester, Steven J. “High Quality Factor Graphene Varactors for Wireless Sensing Applications,” Applied Physics Letters 99, 163105 (2011), 3 pages. |
Koester, Steven J. “Using the Quantum Capacitance in Graphene to Enable Varactors for Passive Wireless Sensing Applications,” 2011 IEEE Sensors Proceedings, pp. 994-997, 2011 (4 pages). |
Li, Xiao et al., “Digital Health: Tracking Physiomes and Activity Using Wearable Biosensors Reveals Useful Health-Related Information,” PLoS Biology 15.1 (2017): e2001402 (30 pages). |
Ma, Rui et al., “Acetone Sensing Using Graphene Quantum Capacitance Varactors,” 2016 IEEE Sensors, Orlando, FL, 2016 (3 pages). |
Machado, Roberto F. et al., “Detection of Lung Cancer by Sensor Array Analyses of Exhaled Breath,” Am J Respir Crit Care Med, vol. 171, 1286-1291 (2005), 6 pages. |
“Mechanical Data,” DGS (S-PDSO-G10) DSC0010B Package Outline, Example Board Layout, and Stencil Design. Texas Instruments 2016 (5 pages). |
Nakhleh, Morad K. et al., “Diagnosis and Classification of 17 Diseases from 1404 Subjects via Pattern Analysis of Exhaled Molecules,” ACS Nano 2017, 11, 112-125 (14 pages). |
“Nano Mobile Healthcare Inc.,” Company Profile on Reuters.com URL <http://www.reuters.com/finance/stocks/companyProfile?symbol=VNTH.PK> accessed Mar. 17, 2017 (2 pages). |
Navaneethan, Udayakumar et al., “Volatile Organic Compounds in Bile Can Diagnose Malignant Biliary Strictures in the Setting of Pancreatic Cancer: a Preliminary Observation,” Gastrointest Endosc. Dec. 2014;80(6):1038-45 (8 pages). |
“Office Action,” for Japanese Patent Application No. 2019-517196 dated Feb. 4, 2020 (10 pages) with English Translation. |
“Office Action,” for Japanese Patent Application No. 2019-520955 dated Jul. 14, 2020 (10 pages) with English Translation. |
“Office Action,” for Japanese Patent Application No. 2019-563876 dated Nov. 4, 2020 (5 pages) with English Summary. |
Olson, Eric J. et al., “Capacitive Sensing of Intercalated H2O Molecules Using Graphene,” ACS Appl. Mater. Interfaces 2015, 7(46), 25804-25812 (29 pages). |
Oprea, A. et al., “Integrated Temperature, Humidity and Gas Sensors on Flexible Substrates for Low-Power Applications,” 007 IEEE Sensors, Atlanta, GA, 2007, pp. 158-161 (4 pages). |
“Package Materials Information,” Tape and Reel Information and Box Dimensions. Texas Instruments Feb. 13, 2016 (2 pages). |
“Package Option Addendum,” Packaging Information for FDC1004DGSR, DGST, DSCJ, DSCR and DSCT Devices. Texas Instruments May 2015 (2 pages). |
Putta, Chandrababu et al., “Palladium Nanoparticles on Beta-Cyclodextrin Functionalised Graphene Nanosheets: a Supramolecular Based Heterogeneous Catalyst for C-C Coupling Reactions under Green Reaction Conditions,” RSC Adv., 2015, 5, 6652-6660 (9 pages). |
Rojas, Maria T. et al., “Supported Monolayers Containing Preformed Binding-Sites—Synthesis and Interfacial Binding-Properties of a Thiolated Beta-Cyclodextrin Derivative,” J. Am. Chem. Soc. 1995, 117, 336-343 (8 pages). |
“Second Office Action,” for Chinese Patent Application No. 201580056417.2 dated Sep. 25, 2019 (8 pages) with English Summary. |
“Standard Terms and Conditions for Evaluation Modules,” Texas Instruments 2016 (5 pages). |
“Third Office Action,” for Chinese Patent Application No. 201580056417.2 dated Feb. 18, 2020 (9 pages) with English Summary. |
Tripathi, Kumud M et al., “Recent Advances in Engineered Graphene and Composites for Detection of Volatile Organic Compounds (VOCs) and Non-Invasive Diseases Diagnosis,” Carbon 110 (2016)97-129 (34 pages). |
Wang, David “FDC1004: Basics of Capacitive Sensing and Applications,” Application Report SNOA927, Texas Instruments Dec. 2014 (12 pages). |
Wayu, Mulugeta B. et al., “Electropolymerization of Beta-Cyclodextrin onto Multi-Walled Carbon Nanotube Composite Films for Enhanced Selective Detection of Uric Acid,” Journal of Electroanalytical Chemistry 783 (2016), 192-200 (9 pages). |
Zhang, Yao et al., “Capacitive Sensing of Glucose in Electrolytes using Graphene Quantum Capacitance Varactors,” ACS Appl. Mater. Interfaces 2017, 9, 38863-38869 (7 pages). |
Zhang, Yao et al., “Glucose Sensing with Graphene Varactors,” IEEE Sensors, SENSORS 2016—Proceedings, Orlando, FL 2016 (3 pages). |
Zhen, Xue et al., “Noncovalent Monolayer Modification of Graphene Using Pyrene and Cyclodextrin Receptors for Chemical Sensing,” ACS Applied Nano Materials 2018, vol. 1, No. 6 pp. 2718-2726 (9 pages). |
“First Office Action,” for Chinese Patent Application No. 201880032911.9 dated Nov. 3, 2021 (11 pages) with English Summary. |
“Notice of Allowance,” for U.S. Appl. No. 14/883,895 dated Oct. 22, 2021 (18 pages). |
“Response to Communication Pursuant to Rules 161(1) and 162 EPC,” for European Patent Application No. 19828373.1 filed Nov. 8, 2021 (22 pages). |
“Response to Communication Pursuant to Rules 70(2) and 70a(2)/Rule 39(1),” for European Patent Application No. 20214733.6 filed Nov. 23, 2021 (4 pages). |
“Second Office Action,” for Chinese Patent Application No. 201780065376.2 dated Nov. 16, 2021 (8 pages) with English Summary. |
“Written Submission,” in Response to Summons to Attend Oral Proceedings for European Patent Application No. 18731579.1 filed Nov. 30, 2021 (31 pages). |
Groves, William A., et al. “Analysis of Solvent Vapors in Breath and Ambient Air with a Surface Acoustic Wave Sensor Array,” Ann.Occup. Hyg., vol. 45, No. 8, pp. 609-623, 2001 (15 pages). |
“Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 17733246.7 dated Jan. 28, 2022 (6 pages). |
“Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 17794832.0 dated Mar. 7, 2022 (9 pages). |
“First Office Action,” for Chinese Patent Application No. 201810782878.3 dated Feb. 9, 2022 (14 pages) with English Summary. |
“Office Action,” for Japanese Patent Application No. 2018-133996 dated Jan. 25, 2022 (7 pages) with English Translation. |
“Response to Communication Pursuant to Rules 161(1) and 162 EPC,” for European Patent Application No. 19836341.8 filed Jan. 7, 2022 (12 pages). |
“Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 15790739.5 dated Jun. 3, 2022 (5 pages). |
“Decision of Rejection,” for Chinese Patent Application No. 201780065376.2 dated Apr. 1, 2022 (9 pages) with English Translation. |
“Non-Final Office Action,” for U.S. Appl. No. 16/696,348 dated Jun. 20, 2022 (68 pages). |
“Non-Final Office Action,” for U.S. Appl. No. 16/712,255 dated Jun. 23, 2022 (64 pages). |
“Response to Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 17733246.7 filed May 18, 2022 (9 pages). |
“Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 20214733.6 dated Jan. 16, 2023 (5 pages). |
“International Preliminary Report on Patentability,” for PCT Application No. PCT/US2021/026778 dated Nov. 10, 2022 (7 pages). |
“Notice of Allowance,” for U.S. Appl. No. 16/712,255 dated Jan. 20, 2023 (31 pages). |
“Determination of Carbonyl Compounds by High performance Liquid Chromatography (HPLC),” EPA Method 8315A 1996 (34 pages). |
“Final Office Action,” for U.S. Appl. No. 16/696,348 dated Nov. 3, 2022 (39 pages). |
“First Examination Report,” for Australian Patent Application No. 2019224011 dated Apr. 9, 2021 (4 pages). |
“International Preliminary Report on Patentability,” for PCT Application No. PCT/US2019/018741 dated Sep. 3, 2020 (11 pages). |
“International Preliminary Report on Patentability,” for PCT Application No. PCT/US2019/028870 dated Nov. 5, 2020 (11 pages). |
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2019/018741 dated May 6, 2019 (17 pages). |
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2019/028870 dated Aug. 20, 2019 (17 pages). |
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2020/046829 dated Nov. 18, 2020 (15 pages). |
“International Search Report and Written Opinion,” for PCT Application No. PCT/US2022/025004 dated Jul. 25, 2022 (15 pages). |
“Non-Final Office Action,” for U.S. Appl. No. 16/280,635 dated Feb. 10, 2021 (40 pages),. |
“Non-Final Office Action,” for U.S. Appl. No. 16/393,177 dated May 25, 2021 (37 pages). |
“Notice of Allowance,” for U.S. Appl. No. 16/280,635 dated Mar. 31, 2021 (14 pages). |
“Office Action,” for Japanese Patent Application No. 2018-133996 dated Jul. 12, 2022 (4 pages) with English Translation. |
“Response to Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 15790739.5 filed Oct. 12, 2022 (35 pages). |
“Response to Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 17794832.0 filed Jul. 7, 2022 (8 pages). |
“Response to Communication Pursuant to Rules 161(1) and 162 EPC,” for European Patent Application No. 19709268.7 filed Apr. 1, 2021 (12 pages). |
“Response to Communication Pursuant to Rules 161(1) and 162 EPC,” for European Patent Application No. 19733177.0 filed Jun. 4, 2021 (20 pages). |
“Response to Examination Report,” for Australian Patent Application No. 2019224011 filed Jul. 23, 2021 (22 pages). |
“Response to Non-Final Rejection,” dated Feb. 10, 2021 for U.S. Appl. No. 16/280,635, submitted via EFS-Web on Mar. 17, 2021, 16 pages. |
“Response to Non-Final Rejection,” dated Jun. 20, 2022 for U.S. Appl. No. 16/696,348, submitted via EFS-Web on Sep. 20, 2022, 9 pages. |
“Response to Non-Final Rejection,” dated Jun. 23, 2022 for U.S. Appl. No. 16/712,255, submitted via EFS-Web on Sep. 22, 2022, 7 pages. |
“Response to Non-Final Rejection,” dated May 20, 2021 for U.S. Appl. No. 14/883,895, submitted via EFS-Web on Aug. 19, 2021, 12 pages. |
Agbonlahor, Osazuwa, et al.“Adsorbed Molecules as Interchangeable Dopants and Scatterers with a van der Waals Bonding Memory in Graphene Sensors,” ACS Sens. 2020, 5 (7), 2003-2009 (13 pages). |
Allen, Matthew J., et al.“Honeycomb Carbon: A Review of Graphene,” Chem. Rev. 2010, 110, 132-145 (14 pages). |
An, Xiaohong, et al.“Stable Aqueous Dispersions of Noncovalently Functionalized Graphene from Graphite and their Multifunctional High-Performance Applications,” Nano Lett. 2010, 10, 4295-4301 (7 pages). |
Bair, Kenneth W., et al.“(1-Pyrenylmethyl)amino Alcohols, a New Class of Antitumor DNA intercalators. Discovery and Initial Amine Side Chain Structure-Activity Studies,” J. Med. Chem. 1990, 33, 2385-2393 (9 pages). |
Bard, Allen J., et al.“Electrochemical Methods: Fundamentals and Applications,” Wiley New York: 1980; vol. 2 (850 pages). |
Bartosik, Miroslav, et al.“The mechanism and suppression of physisorbed-water caused hysteresis in graphene FET sensors,” ACS Sens., vol. 5, 2940-2949 (2020). (40 pages). |
Biedermann, Frank, et al.“Experimental Binding Energies in Supramolecular Complexes,” Chem. Rev. 2016, 116(9), 5216-5300 (85 pages). |
Bock, Harald, et al.“Helicenes from Diarylmaleimides,” Organic Letters 2014, 16, 1546-1549 (5 pages). |
Boeseken, J. “The Use of Boric Acid for the Determination of the Configuration of Carbohydrates,” Adv. Carbohydr. Chem. 1949, 4, 189-210 (22 pages). |
Brust, Mathias, et al.“Novel Gold-Dithiol Nano-Networks with Non-Metallic Electronic Properties,” Adv. Mater. 1995, 7, No. 9 795-797 (3 pages). |
Brust, Mathias, et al.“Synthesis of Thiol-derivatised Gold Nanoparticles in a Two-phase Liquid-Liquid System,” J. Chem. Soc., Chem. Commun., 1994, 801-802 (2 pages). |
Cancilla, Devon A., et al.“O-(2,3,4,5,6-Pentafluorophenyl)methylhydroxylamine hydrochloride: a versatile reagent for the determination of carbonyl-containing compounds,” Journal of Chromatography, 627 (1992) 1-16 (16 pages). |
Cao, Mengmei, et al.“Electrochemical and Theoretical Study of π-π stacking Interactions between Graphitic Surfaces and Pyrene Derivatives,” J. Phys. Chem. C 2014, 118(5), 2650-2659 (10 pages). |
Capuano, Rosamaria, et al.“Corroles-Porphyrins: A Teamwork for Gas Sensor Arrays,” Sensors, 2015, vol. 15, pp. 8121-8130 (10 pages). |
Chen, Gugang, et al.“Sub-ppt gas detection with pristine graphene,” Applied Physics Letters 101, 053119 (2012) 6 pages. |
Cheng, Zengguang, et al.“Suspended Graphene Sensors with Improved Signal and Reduced Noise,” Nano Lett. 2010, 10, 1864-1868 (5 pages). |
Connors, Kenneth A., et al.“The Stability of Cyclodextrin Complexes in Solution,” Chem. Rev. 1997, 97, 1325-1357 (34 pages). |
Cui, Menghua, et al.“Graphene-organic two-dimensional charge transfer complexes: inter-molecular electronic transitions and broadband near infrared photoresponse,” J. Phys. Chem. C 2018, 122 (13), 7551-7556 (7 pages). |
Dreyer, Daniel, et al.“The chemistry of graphene oxide,” Chem. Soc. Rev. 2010, 39(1), 228-240 (13 pages). |
Elemans, Johannes A.A.W., et al.“Molecular Materials by Self-Assembly of Porphyrins, Phthalocyanines, and Perylenes,” Adv. Mater. 2006, 18, 1251-1266 (16 pages). |
Fan, Xuge, et al.“Humidity and CO2 gas sensing properties of double-layer graphene,” Carbon 127 (2018) 576-587 (12 pages). |
Fogel, Yulia, et al.“Graphitic Nanoribons with Dibenzo[e,l]pyrene Repeat Units: Synthesis and Self-Assembly,” Macromolecules 2009, 42, 6878-6884 (7 pages). |
Fuchs, Patricia, et al.“Breath gas aldehydes as biomarkers of lung cancer,” Int. J. Cancer 2010, 126 (11), 2663-70 (8 pages). |
Gao, Zhaoli, et al.“Scalable Production of Sensor Arrays Based on High-Mobility Hybrid Graphene Field Effect Transistors,” ACS Applied Materials & Interfac. 2016, 8(41), 27546-27552 (8 pages). |
Gautam, Madhav, et al.“Gas sensing properites of graphene synthesized by chemical vapor deposition,” Materials and Science Engineering C31 (2011) 1405-1411 (7 pages). |
Gavartin, J.L., et al.“The role of nitrogen-related defects in high-k dialectric oxides: Density-functional studies.,” Journal of Applied Physics. vol. 97, Issue 5 (2005). (15 pages). |
Geim, A.K., et al.“The rise of graphene,” Nat. Mater. 2007, 6, 183-191 (9 pages). |
Georgakilas, Vasilios, et al.“Functionalization of Graphene: Covalent and Non-Covalent Approaches, Derivatives and Applications,” Chem. Rev. 2012, 112(11), 6156-6214 (59 pages). |
Ghosh, Sujoy, et al.“Effect of 1-Pyrene Carboxylic-Acid Functionalization of Graphene on Its Capacitive Energy Storage,” J. Phys. Chem. C 2012, 116, 20688-20693 (6 pages). |
Giancane, Gabriele, et al.“State of Art in Porphyrin Langmuir-Blodgett Films as Chemical Sensors,” Advances in Colloid and Interface Science, 2012, vol. 171-172, pp. 17-35 (Year: 2012), 19 pages. |
Good, Robert J.“Contact angle, wetting, and adhesion: a critical review,” J. Adhesion Sci. Technol. 1992, vol. 6, No. 12, pp. 1269-1302 (34 pages). |
Gorodetsky, Alon A., et al.“Electrochemistry Using Self-assembled DNA Monolayers on Highly Oriented Pyrolytic Graphite,” Langmuir 2006, 22, 7917-7922 (6 pages). |
Guo, Zanru, et al.“Light-Switchable Single-Walled Carbon Nanotubes Based on Host-Guest Chemistry,” Adv. Funct. Mater. 2013, 23, 5010-5018 (18 pages). |
Hasobe, Taku “Photo- and Electro-Functional Self-Assembled Architectures of Porphyrins,” Physics Chemistry Chemical Physics, 2012, 14, pp. 15975-15987 (Year: 2012), 13 pages. |
Hayasaka, Takeshi, et al.“The influences of temperature, humidity, and O2 on electrical properties of graphene FETs,” Sensors & Actuators: B. Chemical 285 (2019) 116-122 (7 pages). |
Hill, Ernie W., et al.“Graphene Sensors,” IEEE Sensors Journal, vol. 11, No. 12, Dec. 2011 (10 pages). |
Hinnemo, Malkolm, et al.“On Monolayer Formation of Pyrenebutyric Acid on Graphene,” Langmuir, 2017, vol. 33, No. 14 pp. 3588-3593 (6 pages). |
Hockstein, Neil G., et al.“Diagnosis of Pneumonia with an Electronic Nose: Correlation of Vapor Signature with Chest Computed Tomography Scan Findings,” The Laryngoscope 2004, 114 (10), 1701-1705 (5 pages). |
Hong Chan, Wing, et al.“Optodes based on a calixarene ester for the determination of aldehydes via in situ generation of the Girard's reagent P derivative,” Analyst 1998, 123 (12), 2851-2856 (6 pages). |
Hsiao, Min-Chien, et al.“Preparation and properties of a graphene reinforced nanocomposite conducting plate,” J. Mater. Chem., 2010, 20, 8496-8505 (10 pages). |
Hsieh, Chien-Te, et al.“Field emission from various CuO nanostructures,” Applied Physics Letters 2003, vol. 83, No. 6 (3 pages). |
Huang, Ke-Jing, et al.“Novel electrochemical sensor based on functionalized graphene for simultaneous determination of adenine and guanine in DNA,” Colloids and Surfaces B: Biointerfaces 82 (2011) 543-549 (7 pages). |
Hunter, Christopher A., et al.“The Nature of π-π Interactions,” J. Am. Chem. Soc. 1990, 112, 5525-5534 (10 pages). |
Hwang, Michael, et al.“Ultrasensitive detection of nucleic acids using deformed graphene channel field effect biosensors,” Nat.Commun. 2020, 11(1) (11 pages). |
Tezhokin, I., et al.“Porphyrin molecules boost the sensitivity of epitaxial graphene for NH3 detection,” J. Phy.: Condens. Matter 29 (2017) (11 pages). |
Ionescu, Radu, et al.“Detection of Multiple Sclerosis from exhaled Breath Using Bilayers of Polycyclic Aromatic Hydrocarbons and Single-Wall Carbon Nanotubes,” ACS Chemical Neurosci. 2011, 2(12), 687-693 (7 pages). |
Jiao, Dezhi, et al.“Supramolecular Peptide Amphiphile Vesicles through Host-Guest Complexation,” Angew. Chem. Int. Ed. 2012, 51, 9633-9637 (5 pages). |
Kang, Junmo, et al.“Graphene Transfer: key for applications,” Nanoscale, 2012, 4, 5527 (11 pages). |
Kang, Xinhuang, et al.“Glucose Oxidase-graphene-chitosan modified electrode for direct electrochemistry and glucose sensing,” Biosensors and Bioelectronics 25 (2009) 901-905 (5 pages). |
Knipp, Ralph J., et al.“A versatile probe for chemoselective capture and analysis of carbonyl compounds in exhaled breath,” Anal Methods, 2015, 7, 6027 (7 pages). |
Kobayashi, Keiko, et al.“Gas chromatrographic determination of low-molecular-weight carbonyl compounds in aqueous solution as their O-(2,3,4,5,6-pentafluorobenzyl) oximes,” Journal of Chromatography A 1980, 187(2), 413-417 (5 pages). |
Kozbial, Andrew, et al.“Study on the surface energy of graphene by contact angle measurement,” Langmuir 2014, 30 (28), 8598-8606 (28 pages). |
Kuila, Tapas, et al.“Chemical functionalization of graphene and its applications,” Progress in Materials Science 57 (2012) 1061-1105 (45 pages). |
Lauffer, Peter, et al.“Molecular and electronic structure of PTCDA on bilayer graphene on SiC(0001) studied with scanning tunnerling microscopy,” Phys. Stat. Sol. (b) 2008, 245, No. 10, 2064-2067 (4 pages). |
Lechner, Christoph, et al.“Adhesive Forces Between Aromatic Molecules and Graphene,” The Journal of Physical Chemistry C 2014, 118(36), 20970-20981 (12 pages). |
Lecourt, Thomas, et al.“Triisobutylaluminium and Diisobutylaluminium Hydride as Molecular Scalpels: the Regioselective Stripping of Perbenzylate Sugars and Cyclodextrins,” Chem. Eur. J. 2004, 10, 2960-2971 (12 pages). |
Li, Errui, et al.“Aliphatic Aldehyde Detection and Adsorption by Nonporous Adaptive Pillar[4]arene[1]quinone Crystals with Vapochromic Behavior,” ACS Applied Materials & Interfaces, 2018, 10, 23147-23153 (23 pages). |
Li, Mingxiao, et al.“Preconcentration and Analysis of Trace Volatile Carbonyl Compounds,” Anal Chem 2012, 84(3), 1288-1293 (6 pages). |
Lienerth, Peter, et al.“Improving the Selectivity to Polar Vapors of OFET-Based Sensors by Using the Tranfser Charactersitics Hysteresis Response,” Sensors and Actuators B 225 (2016) 90-95 (6 pages). |
Liu, Sophie F., et al.“Single-walled Carbon Nanotube-Metalloporphyrin Chemiresistive Gas Sensor Arrays for Volatile Organic Compounds,” Chemistry of Materials, vol. 27, No. 10 (2015) pp. 3560-3563 (5 pages). |
Liu, Yifei M., et al.“Electrochemical Sensing of Nitric Oxide with Functionalized Graphene Electrodes,” ACS Applied Materials & Interfaces 2013, 5(23), 12624-12630 (7 pages). |
Liu, Yuxin, et al.“Biological and Chemical Sensors based on Graphene Materials,” Chem. Soc. Rev. 2012, 41 (6), 2283-2307 (27 pages). |
Loh, Kian Ping, et al.“The Chemistry of Graphene,” J. Mater. Chem., 2010, 20, 2277-2289 (13 pages). |
Long, Brenda, et al.“Non-Covalent Functionalization of Graphene Using Self-Assembly of Alkane-Amines,” Adv. Funct. Mater. 2012, 22, 717-725 (9 pages). |
Lu, Chun-Hua, et al.“A Graphene Platform for Sensing Biomolecules,” Angew. Chem. Int. Ed. 2009, 48, 4785-4787 (3 pages). |
Mackin, Charles, et al.“Chemiresistive Graphene Sensors for Ammonia Detection,” ACS Appl. Mater. Interfaces 2018, 10, 16169-16176 (8 pages). |
Mann, Jason A., et al.“Improving the Binding Characteristics of Tripodal Compounds on Single Layer Graphene,” American Chemical Society 2013, vol. 7, No. 8, 7193-7199 (7 pages). |
Manochehry, Sepehr, et al.“Optical biosensors utilizing graphene and functional DNA molecules,” J. Mater. Res. 2017, 32(15), 2973-2983 (11 pages). |
Manolis, Antony “The Diagnostic Potential of Breath Analysis,” Clin. Chem. 29/1, 5-15 (1983) (11 pages). |
Mao, Shun, et al.“Specific Protein Detection Using Thermally Reduced Graphene Oxide Sheet Decorated with Gold Nanoparticle-Antibody Conjugates,” Adv. Mater. 2010, 22, 3521-3526 (6 pages). |
McCulloch, Michael, et al.“Diagnostic Accuracy of Canine Scent Detection in Early-and Late-Stage Lung and Breast Cancers,” Integrative Cancer Therapies 2006, 5(1), 30-39 (11 pages). |
Moldoveanu, Serban C., et al.“Derivatization Methods in GC and GC/MS,” in Gas Chromatography-Derivatization, Sample Preparation, Application, Kusch, P., Ed. IntechOpen:2018 (33 pages). |
Muruganathan, Manoharan, et al.“Electrically Tunable van der Waals Interaction in Graphene—Molecule Complex,” Nano Lett. 2015, 15(12), 8176-8180 (5 pages). |
Nag, Sanada, et al.“Ultrasensitive QRS made by supramolecular assembly of functionalized cyclodextrins and graphene for the detection of lung cancer VOC biomarkers,” Journals of Materials Chemistry B 2014, 2, pp. 6571-6579 (9 pages). |
Novoselov, K.S., et al.“Electric Field Effect in Atomically Thin Carbon Films,” Science 2004, 306, 666-669 (5 pages). |
Ohno, Yasuhide, et al.“Electrolyte-Gated Graphene Field-Effect Transistors for Detecting pH and Protein Adsorption,” Nano Letters 2009, vol. 9, No. 9, 3318-3322 (5 pages). |
Olson, Eric J., et al.“Getting More out of a Job Plot: Determination of Reactant to Product Stoichiometry in Cases of Displacement Reactions and n:n Complex Formation,” J. Org. Chem. 2011, 76, 8406-8412 (7 pages). |
Ou, Baoli, et al.“Covalent functionalization of graphene with poly(methyl methacrylate) by atom transfer radical polymerization at room temperature,” Polym. Chem., 2012, 3, 2768 (8 pages). |
Park, Eun Uk, et al.“Correlation between the sensitivity and the hysteresis of humidity sensors based on graphene oxides,” Sensors and Actuators B 258 (2018) 255-262 (8 pages). |
Pathipati, Srinivasa Rao, et al.“Modulation of charge transport properties of reduced graphene oxide by submonolayer physisorption of an organic dye,” Organic Electronics 14 (2013) 1787-1792 (6 pages). |
Peng, Gang, et al.“Diagnosing lung cancer in exhaled breath using gold nanoparticles,” Nature nanotechnology, 2009, 4(10), 669-673 (5 pages). |
Peressi, Maria “Surface Functionalization of Graphene,” Graphene Chemistry, John Wiley & Sons, Ltd:2013, pp. 233-253 (21 pages). |
Poli, Diana, et al.“Determination of aldehydes in exhaled breath of patients with lung cancer by means of on-fiber-derivatisation SPME-GC/MS,” Journal of Chromatography B, 878 (2010) 2643- 2651 (9 pages). |
Poulston, S., et al.“Surface Oxidation and Reduction of CuO and Cu2O Studied Using XPS and XAES,” Surface and Interface Analysis, vol. 24, 811-820, 1996, (10 pages). |
Pyo, Soonjae, et al.“Improved photo- and chemical-responses of graphene via porphyrin-functionalization for flexible, transparent, and sensitive sensors,” Nanotechnology 30 (2019) 215501 (9 pages). |
Rekharsky, Mikhail V., et al.“Complexation Thermodynamics of Cyclodextrins,” Chem. Rev. 1998, 98, 1875-1917 (44 pages). |
Reuillard, B., et al.“Non-covalent double functionalization of carbon nanotubes wiht a NADH oxidation Ru(II)-based molecular catalyst and a NAD-dependent glucose dehydrogenase,” Chem. Commun. 2014, 50(79), 11731-11734 (5 pages). |
Rodner, Marius, et al.“Graphene Decorated with Iron Oxide Nanoparticles for Highly Sensitive Interaction with Volatile Organic Compounds,” Sensors 2019, 19, 918-026 (9 pages). |
Rushi, A.D., et al.“Exercising Substituents in porphyrins for real time selective sensing of volatile organic compounds,” Sensors and Actuators B: Chemical, vol. 257, 2018, pp. 389-397 (9 pages). |
Schedin, F., et al.“Detection of Individual Gas Molecules Adsorbed on Graphene,” Nat. Mater. 2007, 6(9), 652-655 (11 pages). |
Shao, Yuyan “Graphene Based Electrochemical Sensor and Biosensors: a Review,” Electroanalysis 2010, 22, No. 10, 1027-1036 (10 pages). |
Shao, Yuyan, et al.“Nitrogen-doped graphene and its electrochemical applications,” J. Mater. Chem., 2010, 20, 7491-7496 (6 pages). |
Song, Nan, et al.“Applications of pillarenes, an emerging class of synthetic macrocycles,” Science China Chemistry, 2014, 57(9), 1185-1198 (15 pages). |
Su, Qun, et al.“Understanding Sources of Electrical Disorder in Graphene Grown by Chemical Vapor Deposition for Wafer-Scale Device Applications,” ACS Appl. Nano Mater., vol. 2 (2019) 3426-3433 (26 pages). |
Suk, Ji Won, et al.“Transfer of CVD-Grown Monolayer Graphene onto Arbitrary Substrates,” ACS Nano 2011, 5(9), 6916-6924 (10 pages). |
Swanson, Emily, et al.“Self Assembly of Monolayers on Graphene with Pyrene and Cyclodextrin Derivatives,” Research Poster. Elon University, LANDO program, Research Experience for Undergraduates Program of the National Science Foundation, Council of Undergraduate Research Experiences for Undergraduates symposium in Washington, D.C., Oct. 23-24, 2016 (1 page). |
Szejtli, Jozef “Introduction and General Overview of Cyclodextrin Chemistry,” Chem. Rev. 1998, 98, 1743-1753 (12 pages). |
Terse-Thakoor, Trupti, et al.“Graphene based biosensors for healthcare,” J. Mater. Res. 2017, 32(15), 2905-2929 (25 pages). |
Turkevich, John, et al.“A study of the nucleation and growth processes in the synthesis of colloidal gold,” Discuss. Faraday Soc., 1951,11, 55-75 (23 pages). |
Vincent, Mark A., et al.“Accurate Prediction of Adsorption Energies on Graphene, Using a Dispersion-Corrected Semiempirical Method Including Solvation,” J. Chem. Inf. Model. 2014, 54, 2225-2260 (6 pages). |
Wang, Lihua “A novel [beta]-cyclodextrin Functionalized Reduced Graphene Oxide Electrochemical Sensor for Blood Glucose Detection,” International Journal of Electrochemical Science, Dec. 28, 2017 pp. 1594-1602 (9 pages). |
Wang, Qing Hua, et al.“Room-temperature molecular-resolution characterization of self-assembled organic monolayers on epitaxial graphene,” Nature Chemistry 2009 vol. 1 (3), 206-211 (6 pages). |
Wei, Jinwei, et al.“Understanding asymmetric transfer characteristics and hysteresis behaviors in graphene devices under different chemical atmospheres,” Carbon 156 (2020) 67-76 (10 pages). |
Wu, Ting, et al.“Quantitative principles for precise engineering of sensitivity in carbon-based electrochemical sensors,” Adv. Mater. 2018,1805752 (27 pages). |
Xu, Huifeng, et al.“Direct Electrochemixtry and electrocatalysis of hemoglobin protein entrapped in graphene and chitosan composite film,” Talanta 81 (2010) 334-338 (5 pages). |
Xu, Mengjian, et al.“Gate-polarity-dependent doping effects of H2O adsorption on graphene/SiO2 field-effect transistors,” J. Phys. D: Appl. Phys. 53 455301, 2020, (8 pages). |
Xu, Shicai, et al.“Real-time reliable determination of binding kinetics of DNA hybridization using a multi-channel graphene biosensor,” Nat. Commun. 2017, 8(1) 11 pages. |
Xu, Yuxi, et al.“Flexible Graphene Films via te Filtration of Water-Soluble Noncovalent Functionalized Graphene Sheets,” J. Am. Chem. Soc. 2008, 130, 5856-5857 (2 pages). |
Yavari, Fazel, et al.“Graphene-Based Chemical Sensors,” J. Phys. Chem. Lett. 2012, 3, 1746-1753 (8 pages). |
Yildiz, Ibrahim “A DFT Approach to the Mechanistic Study of Hydrozone Hydrolysis,” J. Phys. Chem. A 2016, 120 (20), 3683-92 (25 pages). |
Zhang, Yiheng, et al.“Direct Measurements of the Interaction between Pyrene and Graphite in Aqueous Media by Single Molecule Force Spectroscopy: Understanding the π-π Interactions,” Langmuir 2007, 23, 7911-7915 (5 pages). |
Zhao, Yan-Li, et al.“Noncovalent Functionalization of Single-Walled Carbon Nanotubes,” Accounts of Chemical Research 2009, vol. 42, No. 8. 1161-1171 (12 pages). |
Zheng, Peiru, et al.“Oxidation of graphene with variable defects: alternately symmetrical escape and self-restructuring of carbon rings,” Nanoscale 2020, 12(18), 10140-10148 (10 pages). |
Zhu, Congzhi, et al.“Mingling Electronic Chemical Sensors with Supramolecular Host-Guest Chemistry,” Current Organic Chemistry, 2014, 18, 1957-1964 (8 pages). |
Zhu, Yanwu, et al.“Graphene and Graphene Oxide: Synthesis, Properties, and Applications,” Adv. Mater. 2010, 22, 3906-3924 (19 pages). |
“Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 17794832.0 dated Mar. 16, 2023 (7 pages). |
“Non-Final Office Action,” for U.S. Appl. No. 16/696,348 dated Mar. 24, 2023 (22 pages). |
“Response to Communication Pursuant to Article 94(3) EPC,” for European Patent Application No. 20214733.6 filed May 23, 2023 (45 pages). |
“Response to Final Rejection,” dated Nov. 3, 2022, for U.S. Appl. No. 16/696,348, submitted via EFS-Web on Mar. 3, 2023, 11 pages. |
“Second Office Action,” for Chinese Patent Application No. 201810782878.3 dated Feb. 25, 2023 (4 pages) with English Summary. |
Huang, Qing-An, et al. “LC Passive Wireless Sensors Toward a Wireless Sensing Platform: Status, Prospects, and Challenges,” Journal of Microelectromechanical Systems, vol. 25, No. 5, Oct. 2016, https://ieeexplore.ieee.org/abstract/document/7558121 (20 pages). |
Number | Date | Country | |
---|---|---|---|
20210148848 A1 | May 2021 | US |
Number | Date | Country | |
---|---|---|---|
62533916 | Jul 2017 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16037218 | Jul 2018 | US |
Child | 17101900 | US |